ArticleInternational journal of cancer2019

ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.

Prajish Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.